SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

Back To Search Results

S39 - Movement Disorders: Functional and Structural Imaging in Parkinson's Disease

Event Time: Thursday April 27, 2017 1:00 pm to 3:00 pm
Topic(s): Movement Disorders
Director(s):
Description: A group of abstracts covering a similar topic presented in an oral format. Presentations are eight minutes in length with four minutes of question and answer. Each session concludes with 25 minutes of a discussant bringing additional context to one or more of the abstracts.
Completion Message:
CME Credits: 2
Core Competencies:

Program Speakers - Tentative

Start/End Time Title Faculty
2:35 PM - 3:00 PM Discussion Daniel Claassen MD 

Disclosures

Speaker Disclosure
Daniel O. Claassen, MD Personal compensation for activities with Lundbeck, Teva Neuroscience, AbbVie. Grant Support: NIH/ NINDS, Michael J Fox Foundation, Auspex, Vaccinex, CHDI, C2N/Abbvie, Huntington Disease Society of America.

Abstract Presenters

Start Time Pub. Title Presenter
1:00 PM 001 Volumetric analysis of limbic structures in patients with functional movement disorders Carine Maurer, MD, PhD
Disclosure:
Dr. Maurer has nothing to disclose.

1:12 PM 002 Inferior parietal cortex as a hub of loss of inhibition and maladaptive plasticity Kristina Simonyan
Disclosure:
Dr. Simonyan has received personal compensation for activities with Dystonia Medical Research Foundation as an advisor.

1:24 PM 003 Distinct Mesocorticolimbic blood flow response to dopamine therapy in patients with Parkinson′s disease and compulsive reward-driven behaviors Daniel Claassen, MD
Disclosure:
Personal compensation for activities with Lundbeck, Teva Neuroscience, AbbVie. Grant Support: NIH/ NINDS, Michael J Fox Foundation, Auspex, Vaccinex, CHDI, C2N/Abbvie, Huntington Disease Society of America.

1:36 PM 004 Hippocampal and entorhinal cortex atrophy across the Parkinson′s disease cognitive impairment spectrum Roshni Patel, MD
Disclosure:
Dr. Patel has nothing to disclose.

1:48 PM 005 The effects of different modalities of gait training on brain activation in patients with Parkinson′s disease: an fMRI study Inbal Maidan
Disclosure:
Dr. Mirelman has nothing to disclose.

2:00 PM 006 Effects of Subthalamic Stimulation in Elderly patients with Parkinson′s Disease Vibhash Sharma, MD
Disclosure:
Dr. Sharma has nothing to disclose.

2:12 PM 007 Identification of Usp8 as a toxicity modifying Deubiquitinase for α-synuclein Zoi Alexopoulou, MD, PhD
Disclosure:
Dr. Alexopoulou has nothing to disclose.

2:24 PM 008 Glucose-regulated protein 78 (GRP78) in plasma and CSF is associated with Parkinson′s disease. Deepak Gupta, MBBS
Disclosure:
Dr. Gupta has nothing to disclose.

Register Now

Related Courses

Saturday April 21, 2018

7:00 AM-9:00 AM
C4 Hyperkinetic Movement Disorders: Videodiagnosis and Treatment Steven Frucht MD
9:30 AM-11:30 AM
C14 Parkinson's Disease Update Melissa Nirenberg MD, PhD, FAAN
1:30 PM-3:30 PM
C23 Diagnosis and Treatment of Functional Movement Disorders Mark Hallett MD, FAAN

Sunday April 22, 2018

7:00 AM-9:00 AM
C24 Hot Topics and Controversies in Parkinson's Disease Melissa Nirenberg MD, PhD, FAAN
1:00 PM-3:00 PM
C36 Nonmotor Manifestations of Parkinson's Disease I Charles Adler MD, PhD, FAAN
3:30 PM-5:30 PM
C50 Nonmotor Manifestations of Parkinson's Disease II Charles Adler MD, PhD, FAAN

Monday April 23, 2018

7:00 AM-9:00 AM
C65 Video EEG: Name That Spell Amy Crepeau MD
C58 Balance and Gait Disorders Bastiaan Bloem MD, PhD
1:00 PM-3:00 PM
C67 Evaluating Tremor in the Office Vicki Shanker MD

Wednesday April 25, 2018

7:00 AM-9:00 AM
C139 Paroxysmal Movement Disorders Kailash Bhatia MD, FAAN
1:00 PM-5:30 PM
C158 Clinical Uses of Botulinum Toxin for Dystonia Skills Workshop Diego Torres-Russotto MD, FAAN

Thursday April 26, 2018

7:00 AM-9:00 AM
C176 The Dystonia: Diagnosis, Treatment and Update on Etiologies Rachel Saunders-Pullman MD
1:00 PM-3:00 PM
C186 Cerebellar and Afferent Ataxias: Diagnosis and Management Massimo Pandolfo MD, FAAN
3:30 PM-5:30 PM
C208 Clinical Usefulness of Botulinum Toxin for Spasticity Skills Workshop Allison Brashear MD, MBA, FAAN
6:30 PM-9:30 PM
C212 Case Studies: Unusual Movement Disorders Kailash Bhatia MD, FAAN

MEMBER LOG IN

Forgot Password?